| Literature DB >> 28322701 |
Kristy O Murray, Nicole Evert, Bonny Mayes, Eric Fonken, Timothy Erickson, Melissa N Garcia, Tom Sidwa.
Abstract
We characterized the epidemiology of typhus group rickettsiosis in Texas, USA. During 2003-2013, a total of 1,762 cases were reported to the state health department. The number of diagnosed cases and geographic expansion increased over time. Physician awareness is critical to diagnose and effectively treat rickettsial infections.Entities:
Keywords: Texas; Typhus group; United States; bacteria; fleas; murine typhus; rickettsia; rickettsiosis; vector-borne infections; zoonoses
Mesh:
Year: 2017 PMID: 28322701 PMCID: PMC5367421 DOI: 10.3201/eid2304.160958
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Typhus group rickettsiosis, Texas, 2003–2013. A) Number of reported cases by year. B) Illness onset by epidemic week during the study period, by location; <28°N represents south Texas.
Figure 2Geographic distribution of typhus group rickettsiosis, Texas, 2003–2013. A) County-level cumulative incidence per 100,000 population, 2003–2013, and spread into new geographic areas beginning in 2007. B) Incidence stratified by geographic location; <28°N represents south Texas.
Demographic characteristics and attack rates for typhus group rickettsiosis, Texas, 2003–2013
| Characteristic | Cases, no. (%), n = 1,762 | Census population* | Attack rate† |
|---|---|---|---|
| Sex | |||
| F | 921 (52) | 12,673,281 | 7.3 |
| M | 841 (48) | 12,472,280 | 6.7 |
| Race/ethnicity | |||
| White, non-Hispanic | 429 (24) | 11,397,345 | 3.8 |
| White, Hispanic | 1,133 (64) | 9,460,921 | 12.0 |
| Black | 23 (1) | 2,886,825 | 0.8 |
| Unknown or other | 177 (10) | 1,400,470 | 12.6 |
| Age group, y | |||
| <5 | 40 (2) | 1,928,473 | 2.1 |
| 5–19 | 591 (34) | 5,693,241 | 10.4 |
| 20–39 | 398 (23) | 7,194,139 | 5.5 |
| 40–64 | 575 (33) | 7,727,822 | 7.4 |
|
| 158 (9) | 2,601,886 | 6.1 |
*Based on 2010 Population Census for Texas. †Per 100,000 population.
Clinical and environmental characteristics of reported TGR cases, Texas, 2003–2013*
| Characteristic | Total, no. (%) | Confirmed case,† no. (%) | Probable case,‡ no. (%) |
|---|---|---|---|
| Clinical features | |||
| Hospitalized | 1,047/1,758 (59.6) | 473/767 (61.7) | 574/991 (57.9) |
| Fever | 1,747/1,752 (99.7) | 759/764 (99.3) | 988/988 (100) |
| Headache | 1,353/1,753 (77.2) | 569/765 (74.4) | 784/988 (79.4) |
| Chills | 1,228/1,753 (70.1) | 511/765 (66.8) | 717/988 (72.6) |
| Malaise | 1,123/1,753 (64.1) | 471/765 (61.6) | 652/988 (66.0) |
| Anorexia | 925/1,753 (52.8) | 399/765 (52.2) | 526/988 (53.2) |
| Nausea/vomiting | 901/1,753 (51.4) | 381/765 (49.8) | 520/988 (52.6) |
| Myalgia | 890/1,753 (50.8) | 388/765 (50.7) | 502/988 (50.8) |
| Rash | 722/1,700 (42.5) | 325/747 (43.5) | 397/953 (41.7) |
| Diarrhea | 394/1,753 (22.5) | 184/765 (24.1) | 210/988 (21.3) |
| Photophobia | 381/1,752 (21.7) | 160/765 (20.9) | 221/987 (22.4) |
| Retroorbital pain | 266/1,753 (15.2) | 121/765 (15.8) | 145/988 (14.7) |
| Classical triad (fever, headache, rash) | 572/1,697 (33.7) | 240/745 (32.2) | 332/952 (34.9) |
| Abnormal laboratory findings | |||
| Elevated liver function | 478/1,751 (27.3) | 192/765 (25.1) | 286/986 (29.0) |
| Thrombocytopenia | 290/1,752 (16.6) | 123/765 (16.1) | 167/987 (16.9) |
| Environmental findings | |||
| Fleas present in home | 707/1,310 (54.0) | 313/580 (54.0) | 394/730 (54.0) |
| History of flea bite | 418/1,231 (34.0) | 187/538 (34.8) | 231/693 (33.3) |
| Rodents present | 379/1,312 (28.9) | 192/584 (32.9) | 187/728 (25.7) |
| Wildlife present | 587/1,383 (42.4) | 273/617 (44.2) | 314/764 (41.1) |
| Dogs present | 973/1,452 (67.0) | 411/640 (64.2) | 562/809 (69.5) |
| Cats present | 659/1,427 (46.2) | 298/633 (47.1) | 361/792 (45.6) |
| >1 species present | 844/1,463 (57.7) | 371/644 (57.6) | 472/816 (57.8) |
*Denominators are the number of case-patients for whom the information was available. CF, complement fixation; IFA, immunofluorescent antibody; IHA, indirect hemagglutination antibody; LA, latex agglutination; MA, microagglutination; TGR, typhus group rickettsiosis. †A confirmed case was defined as clinically compatible illness with 1) a >4-fold rise in antibody titer by IFA, CF, LA, MA, or IHA between acute and convalescent specimens; 2) a positive PCR result; 3) bacterial isolation from a clinical specimen; 4) positive immunofluorescence from tissue; or 5) a single IgM or IgG titer of >1,024 in a TGR-endemic region of south Texas (beginning in 2007) or Travis County (beginning in 2012). ‡A probable case was defined as clinically compatible illness and a single serologic titer of >128 by IFA, LA, MA, or IHA or a single titer >16 by CF.